• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 药品评价-循证医学研究 • 上一篇    下一篇

基于Meta分析的小金丸治疗乳腺增生疗效评价

孙利昆,柳芳,陈文倩,李朋梅,张相林   

  1. 北京中医药大学中药学院,中日友好医院北京,中日友好医院北京,中日友好医院北京,中日友好医院北京
  • 收稿日期:2015-12-24 修回日期:2016-02-21 出版日期:2016-10-25 发布日期:2016-10-25

Systematic Evaluation on Xiao Jin Pill Treatment of Hyperplasia of Mammary Glands

孙利昆,,, and   

  1. School of Chinese Materia Medica,Bei Jing University OF Chinese Medicine,,,,
  • Received:2015-12-24 Revised:2016-02-21 Online:2016-10-25 Published:2016-10-25

摘要: 目的:评价小金丸(人工麝香、木鳖子、制草乌、枫香脂、乳香、没药、醋炒五灵脂、酒当归、地龙、香墨)治疗乳腺增生的临床疗效和安全性。方法:通过中国知网(CNKI)、维普(VIP)、万方(WF)、中国生物医学文献光盘 (CBMdisk)、Pubmed、Cochrane library数据库,检索收集小金丸治疗乳腺增生临床随机对照研究(RCT)的文献。采用NoteExpress文献管理工具筛选符合纳入标准的文献,应用Cochrane Handbook提供的文献质量风险评价表进行评价,运用RevMan 5.2.3.0统计软件进行Meta分析。结果:符合纳入标准的文献共6篇,包含患者858例,其中对照组372例,实验组486例。Meta分析结果显示,在常规西药治疗基础上,联合小金丸治疗乳腺增生的临床总疗效率优于对照组,差异有统计学意义[OR=2.71,95%CI(1.79,4.12), P<0.00001];在常规西药治疗基础上,联合小金丸治疗乳腺增生的临床治愈率明显高于对照组,差异有统计学意义[OR=1.47,95%CI(1.11,1.96),P=0.008]。结论:小金丸与单用常规西药治疗乳腺增生临床疗效更好、无明显不良反应。

Abstract: Objective: Evaluation xiao jin pills (artificial musk, momordica, kusnezoffii, maple and balsam, frankincense, myrrh, cuchao wulingzhi, wine angelica, earthworm, incense ink) clinical efficacy and safety of breast hyperplasia. Methods: Through Chinese hownet CNKI, VIP, WanFang, Chinese biomedical literature CD (CBMdisk), Pubmed, the Cochrane library database, retrieval collects xiao jin pill treatment of mammary gland hyperplasia clinical randomized controlled studies (RCT). Management tool selection of Note Express literature into standard documents, evaluate the quality of documents provided by the Cochrane Handbook risk evaluation of the application, use RevMan 5.2.3.0 statistical software for Meta-analysis.Results: Included in the standard, a total of 6 references, including 858 cases of patients, including control group 372 examples, the experimental group 486. Meta-analysis results show that on the basis of conventional western medicine treatment, joint xiao jin pill in the treatment of mammary gland hyperplasia total efficacy rate is better than that of control group, the difference was statistically significant [OR=2.71, 95% CI (1.79, 4.12), P<0.00001]; Joint xiao jin pill on the basis of conventional western medicine treatment, clinical cure rate of treatment of mammary gland hyperplasia was obviously higher than that of control group, the difference was statistically significant [OR=1.47, 95% CI (1.11, 1.96), P=0.008]. Conclusion: Xiao jin pill on conventional western medicine treatment of mammary gland hyperplasia clinical curative effect is better, no obvious adverse reactions.